Nomura Holdings’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Nomura Holdings’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14,313	Closed	-$1.89M	–	2055
2025 Q1	$1.89M	Buy	+14,313	New	+$1.78M	﹤0.01%	1084
2024 Q3	–	Sell	-3,005	Closed	-$206K	–	2069
2024 Q2	$206K	Buy	+3,005	New	+$208K	﹤0.01%	1603
2023 Q2	–	Sell	-21,909	Closed	-$1.19M	–	1692
2023 Q1	$1.19M	Sell	21,909 -68,330	-76%	-$3.3M	﹤0.01%	962
2022 Q4	$4.77M	Sell	90,239 -77,458	-46%	-$3.88M	0.02%	509
2022 Q3	$7.8M	Buy	+167,697	New	+$8.76M	0.03%	415

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Nomura Holdings's ITCI Position: Q2 2025 in Review

Nomura Holdings sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 14,313 shares — an estimated $1.89M sold.

Nomura Holdings first reported a position in ITCI in Q3 2022 and held it in 5 quarters. The position peaked at $7.8M in Q3 2022. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Nomura Holdings reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Nomura Holdings sold 14,313 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $1.89M.
Nomura Holdings first reported a position in Intra-Cellular Therapies Inc. in Q3 2022 and held it in 5 quarters.
Nomura Holdings's Intra-Cellular Therapies Inc. position peaked at $7.8M in Q3 2022.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Nomura Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.